Response to: 'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry'' by Mulhearn et al

Affiliations

• ¹ German Rheumatism Research Center (DRFZ Berlin), Epidemiology and Health Care Research, Berlin, Germany.
• ² Centre for Epidemiology Versus Arthritis, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
• ³ National Institute of Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
• ⁴ Instituto de Salud Musculoesquelética, Madrid, Spain.
• ⁵ Division of Rheumatology, Department of Medicine, University of California, San Francisco, CA, USA.
• ⁶ Portuguese League Against Rheumatic Diseases (LPCDR), Lisbon, Portugal.
• ⁷ Standing Committee of People with Arthritis/Rheumatism in Europe (PARE), European Alliance of Associations for Rheumatology (EULAR), Kilchberg, Switzerland.
• ⁸ Institut Pierre Louis d'Epidémiologie et de Santé Publique, INSERM, Sorbonne Universite, Paris, France.
• ⁹ Rheumatology Department, Pitié-Salpêtrière hospital, AP-HP.Sorbonne Université, Paris, France.
• ¹⁰ Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.
• ¹¹ Royal Brisbane & Women's Hospital, Metro North Hospital & Health Service, Herston, Queensland, Australia.
• ¹² Centre for Rheumatology & Department of Neuromuscular Diseases, University College London, London, UK p.machado@ucl.ac.uk.
• ¹³ National Institute for Health Research (NIHR) University College London Hospitals Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK.
• ¹⁴ Department of Rheumatology, Northwick Park Hospital, London North West University Healthcare NHS Trust, London, UK.